Follow
Eleanor Barnes
Eleanor Barnes
Verified email at ndm.ox.ac.uk
Title
Cited by
Cited by
Year
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ...
The Lancet 397 (10269), 99-111, 2021
42702021
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
PM Folegatti, KJ Ewer, PK Aley, B Angus, S Becker, ...
The Lancet 396 (10249), 467-478, 2020
23272020
Global distribution and prevalence of hepatitis C virus genotypes
JP Messina, I Humphreys, A Flaxman, A Brown, GS Cooke, OG Pybus, ...
Hepatology 61 (1), 77-87, 2015
19682015
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
MN Ramasamy, AM Minassian, KJ Ewer, AL Flaxman, PM Folegatti, ...
The Lancet 396 (10267), 1979-1993, 2020
13622020
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four …
M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ...
The Lancet 397 (10277), 881-891, 2021
10702021
Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19
Y Peng, AJ Mentzer, G Liu, X Yao, Z Yin, D Dong, W Dejnirattisai, ...
Nature immunology 21 (11), 1336-1345, 2020
9232020
Evidence of escape of SARS-CoV-2 variant B. 1.351 from natural and vaccine-induced sera
D Zhou, W Dejnirattisai, P Supasa, C Liu, AJ Mentzer, HM Ginn, Y Zhao, ...
Cell 184 (9), 2348-2361. e6, 2021
9132021
Reduced neutralization of SARS-CoV-2 B. 1.617 by vaccine and convalescent serum
C Liu, HM Ginn, W Dejnirattisai, P Supasa, B Wang, A Tuekprakhon, ...
Cell 184 (16), 4220-4236. e13, 2021
5852021
SARS-CoV-2 Omicron-B. 1.1. 529 leads to widespread escape from neutralizing antibody responses
W Dejnirattisai, J Huo, D Zhou, J Zahradník, P Supasa, C Liu, ...
Cell 185 (3), 467-484. e15, 2022
5802022
Antibody evasion by the P. 1 strain of SARS-CoV-2
W Dejnirattisai, D Zhou, P Supasa, C Liu, AJ Mentzer, HM Ginn, Y Zhao, ...
Cell 184 (11), 2939-2954. e9, 2021
5382021
Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor–neutralizing therapy in patients with inflammatory bowel disease
NR West, AN Hegazy, BMJ Owens, SJ Bullers, B Linggi, S Buonocore, ...
Nature medicine 23 (5), 579-589, 2017
5102017
Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man
E Barnes, A Folgori, S Capone, L Swadling, S Aston, A Kurioka, J Meyer, ...
Science translational medicine 4 (115), 115ra1-115ra1, 2012
4772012
Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease
R Banerjee, M Pavlides, EM Tunnicliffe, SK Piechnik, N Sarania, R Philips, ...
Journal of hepatology 60 (1), 69-77, 2014
4732014
Reduced neutralization of SARS-CoV-2 B. 1.1. 7 variant by convalescent and vaccine sera
P Supasa, D Zhou, W Dejnirattisai, C Liu, AJ Mentzer, HM Ginn, Y Zhao, ...
Cell 184 (8), 2201-2211. e7, 2021
4052021
MAIT cells are activated during human viral infections
B Van Wilgenburg, I Scherwitzl, EC Hutchinson, T Leng, A Kurioka, ...
Nature communications 7 (1), 11653, 2016
4042016
Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing properties
E Billerbeck, YH Kang, L Walker, H Lockstone, S Grafmueller, V Fleming, ...
Proceedings of the National Academy of Sciences 107 (7), 3006-3011, 2010
3862010
High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection
GM Lauer, E Barnes, M Lucas, J Timm, K Ouchi, AY Kim, CL Day, ...
Gastroenterology 127 (3), 924-936, 2004
3802004
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
GS Cooke, I Andrieux-Meyer, TL Applegate, R Atun, JR Burry, ...
The lancet Gastroenterology & hepatology 4 (2), 135-184, 2019
3702019
A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory
L Swadling, S Capone, RD Antrobus, A Brown, R Richardson, EW Newell, ...
Science translational medicine 6 (261), 261ra153-261ra153, 2014
3562014
Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: an international registry study
T Marjot, AM Moon, JA Cook, S Abd-Elsalam, C Aloman, MJ Armstrong, ...
Journal of hepatology 74 (3), 567-577, 2021
3212021
The system can't perform the operation now. Try again later.
Articles 1–20